Reducing HIV risk for women

The first long-acting option to protect women from HIV, proven to reduce women’s HIV risk, has been recommended for use by the World Health Organization (WHO). For nearly two decades, researchers from the School of Pharmacy at Queen’s University Belfast have been supporting development of a new drug-releasing vaginal ring to protect women from infection […]

Read More… from Reducing HIV risk for women

End Inequalities, End AIDS, End Pandemics

This World AIDS Day: End Inequalities, End AIDS, End Pandemics: “As if HIV itself were not enough, COVID-19 has brought more fear and insecurities to the communities. I felt the same things with the COVID-19 pandemic that I did when I heard I had the HIV virus—fear, anxiety, stress, and limitations. In the community, they say COVID-19 will be the end of the […]

Read More… from End Inequalities, End AIDS, End Pandemics

Targeted lung health check letter

lung disease

What to do if you receive a letter inviting you for a targeted lung health check: Lung cancer is the UK’s biggest cancer killer. It is the most common cause of death from cancer for both men and women, claiming almost 35,000 lives a year. Early detection of lung cancer makes it more treatable, so […]

Read More… from Targeted lung health check letter

Terrence Higgins Trust: an introduction

Terrence Higgins Trust

Liam Beattie from Terrence Higgins Trust gives a short overview of the work of the charity. Terrence Higgins Trust was one of the first charities to be set up in response to the HIV epidemic and has been at the forefront of the fight against HIV, and improving the nation’s sexual health, ever since. Our […]

Read More… from Terrence Higgins Trust: an introduction

HIV: public knowledge and attitudes report launch webinar

The 2021 UK HIV Public Knowledge and Attitudes Survey is a collaborative piece of research from the National AIDS Trust, Fast Track Cities London and research agency BritainThinks. In this piece of research we have explored what the public thinks, knows and feels about HIV using a combination of quantitative and qualitative methodologies, including: • […]

Read More… from HIV: public knowledge and attitudes report launch webinar

WHO: Classification of Omicron Variant of Concern

omicron

WHO Statement ​– Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behaviour of the virus. The TAG-VE was convened on […]

Read More… from WHO: Classification of Omicron Variant of Concern

The ‘big three’ causes of mouth cancer

the causes of mouth cancer

By knowing the causes of mouth cancer, we can take positive steps to reduce our own level of risk, says a leading health charity. The Oral Health Foundation is raising awareness about the causes of mouth cancer, following new research that shows far too many people remain unaware of the main risk factors. The number […]

Read More… from The ‘big three’ causes of mouth cancer

WHO releases HIV drug resistance report 2021

HIV drug resistance report

WHO’s latest HIV Drug Resistance Report gives an in-depth picture of the extent to which drug resistance is growing, and the steps that countries are taking to ensure people will receive effective medicine to treat and prevent HIV. The report reveals that in 2020, 64% of focus countries (countries with a high burden of HIV infection) had […]

Read More… from WHO releases HIV drug resistance report 2021

HIV antiretroviral therapy reduces cancer risk

antiretroviral

Prompt initiation of antiretroviral therapy reduces cancer risk in HIV patients: HIV patients have an increased risk of developing skin and mucosal cancers, even though HIV is no longer detectable in their blood due to antiretroviral therapy. A new study by MedUni Vienna’s Department of Dermatology, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases […]

Read More… from HIV antiretroviral therapy reduces cancer risk

New tech wound healing

feet hovering over water

Safe and effective – wound healing preparation reaches clinical phase II: APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells. APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore […]

Read More… from New tech wound healing